Skip to content

Legal status · Australia

Is Tirzepatide with BPC-157 legal in Australia?

Written by Reviewed Sep 2026

Not approvedMetabolicStudies in people cited: 1

Direct answer

No. Tirzepatide with BPC-157 is not an approved medicine in Australia. Its legal category is "Not approved". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.

People given it
0
Found nothing
0

Legal category

Not approved

TGA registration and the Poisons Standard schedule, from the Tirzepatide with BPC-157 profile.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Tirzepatide with BPC-157 in Australia at a glance

Legal categoryNot approved
TGA approval statusNot approved by TGA
Studies in people1 of 4 sources on the profile
ReviewedSep 2026

The legal category and note come from the Tirzepatide with BPC-157 profile. We checked them against Therapeutic Goods Administration (TGA) listings on the reviewed date.

What this means

  • 01

    No product containing Tirzepatide with BPC-157 is approved by TGA for any use in Australia. So nothing on sale is allowed for use in people.

  • 02

    "Research use only" is a label sellers put on. It is not a legal category that allows use in people, and it does not get a product out of medicines law.

  • 03

    Importing it, supplying it or promoting it for use in people can fall under medicines law in Australia. This page is general information, not legal advice.

What Tirzepatide with BPC-157 is

The same pairing idea as the semaglutide version. One side has a bigger weight loss effect. The other side is just as empty. Tirzepatide 15 mg cut weight by 20.9% on average at 72 weeks. BPC-157 has five studies in people with under 110 people in all, and none gave it the way it is used here. Nobody has studied the pair. US pharmacies are not allowed to make BPC-157.

Tirzepatide works so well that the muscle question gets sharper than with semaglutide. In the big SURMOUNT-1 study, 57% of people on 15 mg lost 20% or more of their body weight over 72 weeks.

How it works: Tirzepatide copies two gut hormones, GIP and GLP-1. It turns down appetite and slows how fast the stomach empties.

Approval history: Tirzepatide is approved. BPC-157 is not approved. FDA staff reviewed it in July 2026 and found no adequate human data, and pharmacies are not allowed to mix it. The combination has never been reviewed.

How TGA treats this kind of product

Registers or lists medicines and health products on the ARTG, its official register. It also sorts substances into schedules in the Poisons Standard. Many peptides are Schedule 4 (prescription only). So having them without a prescription, or importing them for yourself, is restricted. That is true even when no product is registered.

The legal category above is how The Longevity Archive reads Therapeutic Goods Administration listings for Tirzepatide with BPC-157 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check TGA directly

Tirzepatide with BPC-157 in sport and the military

Whether Tirzepatide with BPC-157 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in Australia. Before you compete or get tested, look up Tirzepatide with BPC-157 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Tirzepatide with BPC-157 in other countries

Frequently asked questions

Is Tirzepatide with BPC-157 legal in Australia?

No. Tirzepatide with BPC-157 is not an approved medicine in Australia. Its legal category is "Not approved". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.

Can I buy Tirzepatide with BPC-157 in Australia?

There is no approved product to buy. In Australia, Tirzepatide with BPC-157 has the legal category "Not approved". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.

Is Tirzepatide with BPC-157 TGA approved?

No. In Australia, Tirzepatide with BPC-157 has the legal category "Not approved". That is not a TGA approval to sell it. For comparison, its US FDA status is: Tirzepatide is approved. BPC-157 is not approved. FDA staff reviewed it in July 2026 and found no adequate human data, and pharmacies are not allowed to mix it. The combination has never been reviewed.. On the evidence, 1 completed human trial is cited on its profile.

Related compounds in Australia

Full research profile

How Tirzepatide with BPC-157 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Tirzepatide with BPC-157 profile

This page is general information about the legal status of Tirzepatide with BPC-157 in Australia, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Therapeutic Goods Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.